{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:38:23Z","timestamp":1762004303817},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urology"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.urology.2010.09.061","type":"journal-article","created":{"date-parts":[[2011,2,6]],"date-time":"2011-02-06T09:09:59Z","timestamp":1296983399000},"page":"855-859","source":"Crossref","is-referenced-by-count":4,"title":["Clinical Utility of Fluorescence In Situ Hybridization for Prediction of Residual Tumor After Transurethral Resection of Bladder Urothelial Carcinoma"],"prefix":"10.1016","volume":"77","author":[{"given":"Tao","family":"Ding","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin-Kui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"You-Han","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luo-Yan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2010.09.061_bib1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","article-title":"Cancer statistics, 2009","volume":"59","author":"Jemal","year":"2009","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urology.2010.09.061_bib2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.juro.2006.08.070","article-title":"Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy?","volume":"177","author":"Herr","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2010.09.061_bib3","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.urology.2003.12.035","article-title":"Impact of transurethral resection of bladder tumor: analysis of cystectomy specimens to evaluate for residual tumor","volume":"63","author":"Lee","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.urology.2010.09.061_bib4","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/j.1464-410X.2006.06144.x","article-title":"The value of a second transurethral resection for T1 bladder cancer","volume":"97","author":"Schwaibold","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2010.09.061_bib5","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/j.1464-410X.2006.06145.x","article-title":"A re-staging transurethral resection predicts early progression of superficial bladder cancer","volume":"97","author":"Herr","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2010.09.061_bib6","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0022-5347(05)00689-0","article-title":"Is a second transurethral resection necessary for newly diagnosed pT1 bladder cancer?","volume":"175","author":"Divrik","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2010.09.061_bib7","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.eururo.2010.03.007","article-title":"Impact of routine second transurethral resection on the long-term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence, progression rate, and disease-specific survival: a prospective randomised clinical trial","volume":"58","author":"Divrik","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2010.09.061_bib8","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0090-4295(01)01522-9","article-title":"Is repeated transurethral resection justified in patients with newly diagnosed superficial bladder cancer?","volume":"59","author":"Schips","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.urology.2010.09.061_bib9","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1097\/01.ju.0000066842.45464.cc","article-title":"Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology","volume":"169","author":"Skacel","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2010.09.061_bib10","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0022-5347(06)00576-3","article-title":"Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria","volume":"176","author":"Sarosdy","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2010.09.061_bib11","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.urology.2007.04.023","article-title":"Comparative diagnostic value of urine cytology, UBC-ELISA, and fluorescence in situ hybridization for detection of transitional cell carcinoma of urinary bladder in routine clinical practice","volume":"70","author":"May","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.urology.2010.09.061_bib12","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.urology.2009.08.082","article-title":"Complete transurethral resection of bladder tumor: are the guidelines being followed?","volume":"75","author":"Adiyat","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.urology.2010.09.061_bib13","series-title":"TNM Classification of Malignant Tumors","first-page":"199","article-title":"Urinary bladder","author":"Sobin","year":"2002"},{"key":"10.1016\/j.urology.2010.09.061_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1440-1827.2009.02477.x","article-title":"Non-invasive papillary urothelial neoplasms: the 2004 WHO\/ISUP classification system","volume":"60","author":"Miyamoto","year":"2010","journal-title":"Pathol Int"},{"key":"10.1016\/j.urology.2010.09.061_bib15","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0022-5347(05)65072-0","article-title":"A comparison of BTA stat, hemoglobin dipstick, telomerase and Vysis Uro-Vysion assays for the detection of urothelial carcinoma in urine","volume":"167","author":"Halling","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2010.09.061_bib16","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.eururo.2008.01.015","article-title":"The schedule and duration of intravesical chemotherapy in patients with non-muscle-invasive bladder cancer: a systematic review of the published results of randomized clinical trials","volume":"53","author":"Sylvester","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2010.09.061_bib17","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000075961","article-title":"Second transurethral resection of superficial transitional cell carcinoma of the bladder: a must even for experienced urologists","volume":"72","author":"Zurkirchen","year":"2004","journal-title":"Urol Int"},{"key":"10.1016\/j.urology.2010.09.061_bib18","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/S0022-5347(05)67104-2","article-title":"A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma","volume":"164","author":"Halling","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2010.09.061_bib19","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.cancergencyto.2006.10.011","article-title":"Utility of a multiprobe FISH assay in the detection of superficial urothelial bladder cancer","volume":"173","author":"Mari\u2032n-Aguilera","year":"2007","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.urology.2010.09.061_bib20","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1016\/j.juro.2008.01.105","article-title":"Prospective evaluation of the clinical usefulness of reflex fluorescence in situ hybridization assay in patients with atypical cytology for the detection of urothelial carcinoma of the bladder","volume":"179","author":"Lotan","year":"2008","journal-title":"J Urol"},{"issue":"suppl 1","key":"10.1016\/j.urology.2010.09.061_bib21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.urology.2006.01.039","article-title":"DNA-based molecular cytology for bladder cancer surveillance","volume":"67","author":"Jones","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.urology.2010.09.061_bib22","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1016\/S0022-5347(05)64270-X","article-title":"Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer","volume":"168","author":"Sarosdy","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2010.09.061_bib23","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1464-410X.2008.07637.x","article-title":"Urinary fibronectin as a predictor of a residual tumour load after transurethral resection of bladder transitional cell carcinoma","volume":"102","author":"Li","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2010.09.061_bib24","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.eururo.2005.09.015","article-title":"Urinary hyaluronan as a marker for the presence of residual transitional cell carcinoma of the urinary bladder","volume":"49","author":"Passerotti","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2010.09.061_bib25","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1464-410X.2003.04528.x","article-title":"Comparison of multitarget fluorescence in situ hybridization in urine with other noninvasive tests for detecting bladder cancer","volume":"92","author":"Friedrich","year":"2003","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2010.09.061_bib26","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.juro.2010.02.026","article-title":"The role of tumor-free status in repeat resection before intravesical bacillus Calmette-Gu\u00e9erin for high grade Ta, T1 and CIS bladder cancer","volume":"183","author":"Guevara","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2010.09.061_bib27","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0022-5347(05)01002-5","article-title":"The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial","volume":"175","author":"Divrik","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2010.09.061_bib28","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1002\/ijc.21704","article-title":"Multi-target fluorescence in situ hybridization in bladder washings for prediction of recurrent bladder cancer","volume":"119","author":"Zellweger","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urology.2010.09.061_bib29","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0302-2838(03)00040-X","article-title":"The value of a second transurethral resection in evaluating patients with bladder tumours","volume":"43","author":"Miladi","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2010.09.061_bib30","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.eururo.2007.01.044","article-title":"Should we abandon the FISH test?","volume":"51","author":"Nieder","year":"2007","journal-title":"Eur Urol"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429510019473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429510019473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T01:27:21Z","timestamp":1543973241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429510019473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0090429510019473"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2010.09.061","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}